[Eisenmenger syndrome. Specific treatments].
Hôpital des Enfants, Toulouse, France. acar.p@chu-toulouse.fr
Philippe
P
Acar
D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use; D000077300:Bosentan; D004541:Eisenmenger Complex / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D065128:Endothelin Receptor Antagonists; D011464:Epoprostenol / Q000031:analogs & derivatives; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000209:etiology; D008017:Life Expectancy; D008297:Male; D015337:Multicenter Studies as Topic; D010166:Palliative Care; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D013449:Sulfonamides / Q000627:therapeutic use
D000959:Antihypertensive Agents; D065128:Endothelin Receptor Antagonists; D010726:Phosphodiesterase Inhibitors; D013449:Sulfonamides; D011464:Epoprostenol; D000077300:Bosentan